Voyager Therapeutics (VYGR) Reports Q2 2026 Financial Results

What Happened
Voyager Therapeutics, Inc. (NASDAQ: VYGR) announced its second-quarter 2026 financial results and corporate updates on August 6, 2026. The company furnished the full press release reporting those results as Exhibit 99.1 to its Current Report on Form 8‑K (Item 2.02), and the exhibit is incorporated by reference into the filing.

Key Details

• Filing date: August 6, 2026 (Form 8‑K).
• Reported item: Item 2.02 — Results of Operations and Financial Condition (second quarter 2026 results and corporate updates).
• Exhibit: Press release is furnished as Exhibit 99.1 and incorporated by reference.
• Administrative item: Item 9.01 (Financial Statements and Exhibits) included for the exhibit filing.

Why It Matters
This 8‑K provides Voyager’s latest quarterly results and corporate updates that investors use to evaluate near‑term performance (earnings, revenue, cash position, or program progress). Retail investors should read the Exhibit 99.1 press release and the company’s upcoming quarterly report for the specific financial figures and management commentary to understand impacts on valuation and outlook.